A number of investment brokers have recently updated their price targets on shares of Biota Pharmaceuticals, Inc. (NASDAQ:BOTA). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

01/27/2016 – Biota Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at HSBC.

12/22/2015 – FBR Capital Markets began new coverage on Biota Pharmaceuticals, Inc. giving the company a “outperform” rating. They now have a USD 6 price target on the stock.

08/04/2014 – Biota Pharmaceuticals, Inc. was downgraded to “neutral” by analysts at Guggenheim. They now have a USD 3 price target on the stock.

05/31/2014 – Biota Pharmaceuticals, Inc. was downgraded to “sell” by analysts at TheStreet.

05/29/2014 – Biota Pharmaceuticals, Inc. was downgraded to “sell” by analysts at ING.

The share price of Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) was up +0.00% during the last day of trading, with a day high of 0.00. 0 shares were traded during the last session.

The stock’s 50 day moving average is 1.55 and its 200 day moving average is 1.80.Biota Pharmaceuticals, Inc. has a 52-week low of 1.23 and a 52-week high of 2.66.

View other investors thoughts on Biota Pharmaceuticals, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.